Literature DB >> 24092616

Looking above but not beyond the genome for therapeutics in neurology and psychiatry: epigenetic proteins and RNAs find a new focus.

Manuela Basso1, Sama Sleiman, Rajiv R Ratan.   

Abstract

Mesh：

Year:  2013        PMID： 24092616      PMCID： PMC3805863          DOI： 10.1007/s13311-013-0225-2

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN： 1878-7479            Impact factor:   7.620


× No keyword cloud information.
  28 in total

Review 1.  Applicability of histone deacetylase inhibition for the treatment of spinal muscular atrophy.

Authors:  Sebastian Lunke; Assam El-Osta
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 2.  Novel protective effects of histone deacetylase inhibition on stroke and white matter ischemic injury.

Authors:  Selva Baltan; Richard S Morrison; Sean P Murphy
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 3.  Epigenetic mechanisms of neurodegeneration in Huntington's disease.

Authors:  Junghee Lee; Yu Jin Hwang; Ki Yoon Kim; Neil W Kowall; Hoon Ryu
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 4.  Epigenetics, autism spectrum, and neurodevelopmental disorders.

Authors:  Sampathkumar Rangasamy; Santosh R D'Mello; Vinodh Narayanan
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

5.  Epigenetics: core misconcept.

Authors:  Mark Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-12       Impact factor: 11.205

Review 6.  The epigenetics of stroke recovery and rehabilitation: from polycomb to histone deacetylases.

Authors:  Jessica Elder; Mar Cortes; Avrielle Rykman; Justin Hill; Saravanan Karuppagounder; Dylan Edwards; Rajiv R Ratan
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 7.  Small molecule inhibitors of zinc-dependent histone deacetylases.

Authors:  Florence F Wagner; Michel Weїwer; Michael C Lewis; Edward B Holson
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 8.  Epigenetics of neural repair following spinal cord injury.

Authors:  Elisa M York; Audrey Petit; A Jane Roskams
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 9.  Sirtuin deacetylases as therapeutic targets in the nervous system.

Authors:  Brett Langley; Anthony Sauve
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

10.  Regulation of A20 and other OTU deubiquitinases by reversible oxidation.

Authors:  Yogesh Kulathu; Francisco J Garcia; Tycho E T Mevissen; Martin Busch; Nadia Arnaudo; Kate S Carroll; David Barford; David Komander
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.